Can the sequence of chemotherapy regimens influence outcome in patients with metastatic pancreatic adenocarcinoma (MPAC)?

被引:1
|
作者
Schmidt, Shannon Leah
Durkal, Vipal
Jayavalsan, Shinoj Pattali
Ritch, Paul S.
Thomas, James P.
Erickson, Beth
Christians, Kathleen K.
Tsai, Susan
Evans, Douglas B.
George, Ben
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Froedtert Hosp, Milwaukee, WI USA
关键词
D O I
10.1200/jco.2016.34.4_suppl.428
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
428
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
    Bange, Erin M.
    Doucette, Abigail
    Gabriel, Peter E.
    Porterfield, Florence
    Harrigan, James J.
    Wang, Robin
    Wojcieszynski, Andrzej P.
    Boursi, Ben
    Mooney, Bethany I.
    Reiss, Kim A.
    Mamtani, Ronac
    JCO ONCOLOGY PRACTICE, 2020, 16 (08) : 504 - +
  • [42] METASTATIC ADENOCARCINOMA OF UNKNOWN PRIMARY SITE - A RANDOMIZED STUDY OF 2 COMBINATION CHEMOTHERAPY REGIMENS
    MILLIKEN, ST
    TATTERSALL, MHN
    WOODS, RL
    COATES, AS
    LEVI, JA
    FOX, RM
    RAGHAVAN, D
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1645 - 1648
  • [43] Multidrug regimens for treatment of older patients with metastatic pancreatic cancer
    Macchini, Marina
    Chiaravalli, Marta
    Pircher, Chiara
    Zanon, Silvia
    Peretti, Umberto
    Mazza, Elena
    Valente, Maria Maddalena
    Fugazza, Clara
    Gianni, Luca
    Reni, Michele
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (01) : 117 - 121
  • [44] Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice
    Berta Laquente
    Teresa Macarulla
    Cristina Bugés
    Marta Martín
    Carlos García
    Carles Pericay
    Sandra Merino
    Laura Visa
    Teresa Martín
    Manuela Pedraza
    Beatriz Carnero
    Raquel Guardeño
    Helena Verdaguer
    Alejandro Mut
    David Vilanova
    Adelaida García
    BMC Palliative Care, 19
  • [45] Thromboembolic events (TE) among patients with metastatic pancreatic ductal adenocarcinoma (mPDA) after chemotherapy (Chemo).
    Lyman, Gary H.
    Schabert, Vernon F.
    Philip, Philip Agop
    Stokes, Michael
    Bhurke, Sharvari
    Kuderer, Nicole M.
    Qadan, Ammar
    Khorana, Alok A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [46] Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice
    Garcia Velasco, A.
    Macarulla, T.
    Buges Sanchez, C.
    Martin, M.
    Garcia, C.
    Pericay, C.
    Merino, S.
    Visa, L.
    Martin, T.
    Pedraza, M.
    Carnero, B.
    Guardeno, R.
    Pellin, L.
    Vilanova, D.
    Laquente, B.
    ANNALS OF ONCOLOGY, 2018, 29 : 45 - 45
  • [47] Outcomes of phosphorus-32 microparticle intratumoural implantation added to chemotherapy in patients with metastatic pancreatic adenocarcinoma
    Lim, A.
    Singhal, N.
    Bartholomeusz, D.
    Zobel, J.
    Naidu, J.
    Hsieh, W.
    Crouch, B.
    Wasan, H.
    Turner, D.
    Nguyen, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S138 - S138
  • [48] Outcomes of phosphorus-32 microparticle intratumoral implantation added to chemotherapy in patients with metastatic pancreatic adenocarcinoma
    Lim, A. H. W.
    Singhal, N.
    Bartholomeusz, D.
    Naidu, J.
    Zobel, J.
    Hsieh, W.
    Crouch, B.
    Wasan, H.
    Croagh, D.
    Nagrial, A.
    Aghmesheh, M.
    Nguyen, N. Q.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 25 - 25
  • [49] Systemic Inflammation Scores Predict the Activity of First-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma
    Colloca, Giuseppe A.
    Venturino, Antonella
    Guarneri, Domenico
    CANCER INVESTIGATION, 2021, 39 (01) : 55 - 61
  • [50] Risks of thromboembolic events among patients diagnosed with metastatic pancreatic ductal adenocarcinoma treated with chemotherapy.
    Bapat, Bela
    Bhurke, Sharvari
    Rosen, Edward
    Stokes, Michael
    Bhagnani, Tarun
    Nordstrom, Beth
    Zaknoen, Sara
    Qadan, Ammar
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)